Literature DB >> 10318669

Prevention of sudden cardiac death by dietary pure omega-3 polyunsaturated fatty acids in dogs.

G E Billman1, J X Kang, A Leaf.   

Abstract

BACKGROUND: Rat diets high in fish oil have been shown to be protective against ischemia-induced fatal ventricular arrhythmias. Increasing evidence suggests that this may also apply to humans. To confirm the evidence in animals, we tested a concentrate of the free fish-oil fatty acids and found them to be antiarrhythmic. In this study, we tested the pure free fatty acids of the 2 major dietary omega-3 polyunsaturated fatty acids in fish oil: cis-5,8,11,14, 17-eicosapentaenoic acid (C20:5omega-3) and cis-4,7,10,13,16, 19-docosahexaenoic acid (C22:6omega-3), and the parent omega-3 fatty acid in some vegetable oils, cis-9,12,15-alpha-linolenic acid (C18:3omega-3), administered intravenously on albumin or a phospholipid emulsion. METHODS AND
RESULTS: The tests were performed in a dog model of cardiac sudden death. Dogs were prepared with a large anterior wall myocardial infarction produced surgically and an inflatable cuff placed around the left circumflex coronary artery. With the dogs running on a treadmill 1 month after the surgery, occlusion of the left circumflex artery regularly produced ventricular fibrillation in the control tests done 1 week before and after the test, with the omega-3 fatty acids administered intravenously as their pure free fatty acid. With infusion of the eicosapentaenoic acid, 5 of 7 dogs were protected from fatal ventricular arrhythmias (P<0.02). With docosahexaenoic acid, 6 of 8 dogs were protected, and with alpha-linolenic acid, 6 of 8 dogs were also protected (P<0.004 for each). The before and after control studies performed on the same animal all resulted in fatal ventricular arrhythmias, from which they were defibrillated.
CONCLUSIONS: These results indicate that purified omega-3 fatty acids can prevent ischemia-induced ventricular fibrillation in this dog model of sudden cardiac death.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10318669     DOI: 10.1161/01.cir.99.18.2452

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  83 in total

Review 1.  Unorthodox routes to prostanoid formation: new twists in cyclooxygenase-initiated pathways.

Authors:  C N Serhan; E Oliw
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

Review 2.  Fish oil and omega-3 fatty acids in cardiovascular disease: do they really work?

Authors:  Daan Kromhout; Satoshi Yasuda; Johanna M Geleijnse; Hiroaki Shimokawa
Journal:  Eur Heart J       Date:  2011-09-19       Impact factor: 29.983

3.  Role of redox state in modulation of ion channel function by fatty acids and phospholipids.

Authors:  Zhiguo Wang
Journal:  Br J Pharmacol       Date:  2003-06       Impact factor: 8.739

Review 4.  Effects of supplementation with polyunsaturated fatty acids in patients with heart failure.

Authors:  Savina Nodari; Marco Triggiani; Alessandra Manerba; Giuseppe Milesi; Livio Dei Cas
Journal:  Intern Emerg Med       Date:  2011-10       Impact factor: 3.397

5.  Omega-3 polyunsaturated fatty acids (PUFAs or fish oils) and atrial fibrillation.

Authors:  T Opthof; H M Den Ruijter
Journal:  Br J Pharmacol       Date:  2006-12-18       Impact factor: 8.739

Review 6.  Discovery of specialized pro-resolving mediators marks the dawn of resolution physiology and pharmacology.

Authors:  Charles N Serhan
Journal:  Mol Aspects Med       Date:  2017-03-03

Review 7.  Are omega-3 fatty acids the most important nutritional modulators of coronary heart disease risk?

Authors:  William S Harris
Journal:  Curr Atheroscler Rep       Date:  2004-11       Impact factor: 5.113

Review 8.  Extending the cardiovascular benefits of omega-3 Fatty acids.

Authors:  William S Harris
Journal:  Curr Atheroscler Rep       Date:  2005-09       Impact factor: 5.113

9.  Omega-3 fatty acid supplementation for the prevention of arrhythmias.

Authors:  Mina K Chung
Journal:  Curr Treat Options Cardiovasc Med       Date:  2008-09

Review 10.  Methodologic challenges in designing clinical studies to measure differences in the bioequivalence of n-3 fatty acids.

Authors:  Diane H Morris
Journal:  Mol Cell Biochem       Date:  2003-04       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.